BULLETIN V2023-0171
THERALASE TECHNOLOGIES INC. ("TLT")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: December 5, 2023
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced on November 17, 2023:
Number of Shares: 5,318,183 common shares
Purchase Price: $0.22 per common share
Warrants: 5,318,183 common share purchase warrants to purchase 5,318,183 common shares
Warrant Exercise Price: $0.28 per common share for a period of five (5) years
Number of Placees: 28 Placees
Insider / Pro Group Participation:
Placees # of Placee (s) Aggregate # of Shares
Aggregate Existing Insider Involvement: 1 461,282
Aggregate Pro Group Involvement: N/A N/A
Aggregate Cash Amount Aggregate #
of Shares Aggregate #
of Warrants
Finder's Fee: $ 5,810 N/A 18,864
Finder's Warrants Terms: Each warrant entitles the holder to purchase one common share and one common share purchase warrant at a price of $0.22 for a period of five (5) years from the date of issuance, with each underlying warrant is being exercisable into one additional common share at a price of $0.28 per share for a period of five (5) years.
The Company issued a news release on November 29, 2023 confirming closing of the private placement.
________________________________________
|
|
